Dongxing Zha

Company: Alloy Therapeutics

Job title: Chief Technology Officer

Seminars:

KeywayTM TCRm Discovery Targeting the Dark Genome: Case Study Highlighting a Fully Integrated Workflow from Target Idea to Lead Candidate 3:00 pm

Showcasing Keyway™ TCRm Discovery’s fully integrated workflow for generating highly specific and functional TCR mimic (TCRm) antibodies against targets in the dark genome, regions encoding previously unannotated protein or microproteins inaccessible to conventional immunotherapies Highlighting the power of Keyway’s end-to-end discovery platform in unlocking novel cancer targets through delivery of TCRm candidates to multiple partnersRead more

day: Day 1